Dafna Capital Management LLC Soleno Therapeutics Inc Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$1.71 - $2.51 $636,975 - $934,974
-372,500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.77 - $4.23 $659,325 - $1.58 Million
372,500 New
372,500 $827,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $451M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email